Your browser doesn't support javascript.
loading
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen, Peter; Eichhorst, Barbara; Brown, Jennifer R; Lamanna, Nicole; O'Brien, Susan M; Tam, Constantine S; Qiu, Lugui; Kazmierczak, Maciej; Zhou, Keshu; Simkovic, Martin; Mayer, Jirí; Gillespie-Twardy, Amanda; Shadman, Mazyar; Ferrajoli, Alessandra; Ganly, Peter S; Weinkove, Robert; Grosicki, Sebastian; Mital, Andrzej; Robak, Tadeusz; Österborg, Anders; Yimer, Habte A; Salmi, Tommi; Ji, Meng; Yecies, Jessica; Idoine, Adam; Wu, Kenneth; Huang, Jane; Jurczak, Wojciech.
Afiliación
  • Hillmen P; St James's University Hospital, Leeds, United Kingdom.
  • Eichhorst B; Department I of Internal Medicine, Center for Integrated Oncology Aachen, University of Cologne, Bonn, Cologne, Düsseldorf, Germany.
  • Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California, Irvine, CA.
  • Tam CS; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Qiu L; University of Melbourne, Parkville, Victoria, Australia.
  • Kazmierczak M; St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
  • Zhou K; Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Simkovic M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Mayer J; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Gillespie-Twardy A; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Shadman M; 4th Department of Internal Medicine-Hematology, University Hospital, Hradec Kralove, Czech Republic.
  • Ferrajoli A; Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Ganly PS; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital, Brno, Czech Republic.
  • Weinkove R; Blue Ridge Cancer Care, Roanoke, VA.
  • Grosicki S; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Mital A; Department of Medicine, University of Washington, Seattle, WA.
  • Robak T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Österborg A; Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
  • Yimer HA; Wellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, New Zealand.
  • Salmi T; Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Ji M; Department of Hematology and Cancer Prevention, Health Sciences Faculty, Medical University of Silesia, Katowice, Poland.
  • Yecies J; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Idoine A; Medical University of Lodz, Lodz, Poland.
  • Wu K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Huang J; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Jurczak W; Texas Oncology-Tyler/US Oncology Research, Tyler, TX.
J Clin Oncol ; 41(5): 1035-1045, 2023 02 10.
Article en En | MEDLINE | ID: mdl-36395435

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido